510(k) K010668

BAYER DIAGNOSTICS ADVIA CENTAUR RUBELLA IGM ASSAY by Bayer Corp. — Product Code LFX

K010668 is an FDA 510(k) premarket notification submitted by Bayer Corp. for the device "BAYER DIAGNOSTICS ADVIA CENTAUR RUBELLA IGM ASSAY". The FDA issued a decision of Substantially Equivalent on July 5, 2001. The device falls under product code LFX (Enzyme Linked Immunoabsorbent Assay, Rubella), a Class II device regulated under 21 CFR 866.3510. Bayer Corp. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 5, 2001
Date Received
March 6, 2001
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Rubella
Device Class
Class II
Regulation Number
866.3510
Review Panel
MI
Submission Type